MedTrace Logo

Cellulose Sulfate (CS) Gel and HIV in Nigeria

NCT00120770 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 2160

Last updated 2007-02-28

No results posted yet for this study

Summary

This is a Phase 3, multi-center, randomized, placebo-controlled trial to determine the effectiveness and safety of the 6% cellulose sulfate (CS) vaginal gel for the prevention of HIV infection.

Conditions

  • HIV Infections
  • Gonorrhea
  • Chlamydia Infections

Interventions

DRUG

Cellulose Sulfate Vaginal Gel (Microbicide)

Sponsors & Collaborators

  • Lagos State University

    collaborator OTHER

  • University of Port Harcourt Teaching Hospital

    collaborator OTHER

  • FHI 360

    lead OTHER

Principal Investigators

  • Vera Halpern, MD · FHI 360

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-11-30
Completion
2007-03-31

Countries

  • Nigeria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00120770 on ClinicalTrials.gov